Advertisement

Cellular and Molecular Life Sciences

, Volume 68, Issue 5, pp 903–917 | Cite as

Bafilomycin A1 activates respiration of neuronal cells via uncoupling associated with flickering depolarization of mitochondria

  • Alexander V. Zhdanov
  • Ruslan I. Dmitriev
  • Dmitri B. Papkovsky
Open Access
Research Article

Abstract

Bafilomycin A1 (Baf) induces an elevation of cytosolic Ca2+ and acidification in neuronal cells via inhibition of the V-ATPase. Also, Baf uncouples mitochondria in differentiated PC12 (dPC12), dSH-SY5Y cells and cerebellar granule neurons, and markedly elevates their respiration. This respiratory response in dPC12 is accompanied by morphological changes in the mitochondria and decreases the mitochondrial pH, Ca2+ and ΔΨm. The response to Baf is regulated by cytosolic Ca2+ fluxes from the endoplasmic reticulum. Inhibition of permeability transition pore opening increases the depolarizing effect of Baf on the ΔΨm. Baf induces stochastic flickering of the ΔΨm with a period of 20 ± 10 s. Under conditions of suppressed ATP production by glycolysis, oxidative phosphorylation impaired by Baf does not provide cells with sufficient ATP levels. Cells treated with Baf become more susceptible to excitation with KCl. Such mitochondrial uncoupling may play a role in a number of (patho)physiological conditions induced by Baf.

Keywords

Bafilomycin A1 Mitochondrial uncoupling Oxygen sensing Neuronal cells Calcium Bioenergetics Respiration V-ATPase 

Introduction

Since being described as an inhibitor of vacuolar H+-ATPase (V-ATPase) [1], plecomacrolide bafilomycin A1 (Baf) has become a powerful pharmacological tool in cell physiology research. V-ATPases comprise a family of structurally conserved proteins with multiple functions, which pump protons against the concentration gradient into acidic organelles, and create conditions for protein degradation, receptor–ligand dissociation, and turnover of both neurotransmitters and Ca2+ [2, 3]. In neuronal cells one of their main functions is to provide the driving force for filling vesicles with neurotransmitters (NT) by the vacuolar H+/NT antiporters. Recent study has demonstrated that the V-ATPase is also involved in synaptic vesicle swelling which precedes neurotransmission [4]. As neuronal activity requires frequent NT release and vesicle recharge, V-ATPase consumes a considerable proportion of ATP produced in neurons.

V-ATPase activity is regulated by actin cytoskeleton remodelling, the activity of Cl channels, PI3K signalling, glucose supply, and the assembly of its subunits [2]. Along with Baf, V-ATPases can be inhibited by concanamycin A (CMA) and other pharmacological compounds [5]. Baf [6] interacts with the V0 subunit c [7, 8] and impairs translocation of protons into acidic compartments. Such inhibition has severe implications and leads to lysosome dysfunction, neurotransmission failure, cytosol acidification, impairment of polarized Ca2+ signalling and elevation of cytosolic Ca2+ [2, 9, 10, 11, 12, 13]. The decrease in pH and increase in Ca2+ in the cytosol, in turn, can induce opening of the permeability transition pores (PTP) [14] and cell death. The anticancer effect of Baf is well known and is attributed mainly to the inhibition of autophagy [15] by preventing the fusion of autophagosomes with dysfunctional lysosomes [16, 17], consequently triggering apoptosis [15]. Other mechanisms of cancer inhibition by Baf have also been proposed. Thus, by stabilizing the HIF-1α, Baf has been shown to induce the p21WAF1/Cip1-mediated growth arrest in a number of cancer cell lines and to stimulate direct interaction of the V0 subunit c with HIF-1α [18, 19, 20]. Also, both Baf and CMA induce mitochondrial depolarization and apoptosis in leukaemic monocytes by activating NO production [21]. On the other hand, Baf at subnanomolar concentrations has been shown to inhibit chloroquine-induced caspase-3 activity and apoptosis of the noncancerous cerebellar granule neurons (CGN) [22].

So far, most of the effects of Baf have been attributed to its V-ATPase inhibitory function. Little attention has been paid to its uncoupling effect demonstrated on isolated rat liver mitochondria, which was attributed to its K+ ionophore activity [23]. This, however, may be linked to some of the effects of Baf observed in vitro and in vivo, since mitochondrial uncoupling is implicated in cell and organ-specific toxicity of many drugs [24].

Considering the multiple targets and signalling pathways described for Baf, we undertook a detailed investigation of its effects on the mitochondrial function and bioenergetic parameters of neuronal cells using differentiated neurosecretory PC12 cells (dPC12) as a model. Derived from rat adrenal phaeochromocytoma, dPC12 cells demonstrate gene expression profiles, NT release and other features typical of neuronal cells [25, 26], while both oxidative phosphorylation (OxPhos) and glycolysis serve as effective suppliers of cellular ATP [27, 28]. An intracellular oxygen ( i O2) sensing technique, which allows real-time monitoring of O2 levels in the monolayer of cells, both at rest and upon stimulation [28, 29], was used to study the metabolic effects of Baf on PC12 cells. The results were correlated with the other key metabolic markers and parameters of cellular function. The effects found in dPC12 cells were subsequently confirmed in differentiated neuroblastoma SH-SY5Y cells and CGN from rat brain.

Materials and methods

Materials

PC12 and SH-SY5Y cells were obtained from the European and American collections of cell cultures. The oxygen-sensitive probe MitoXpress and extracellular acidification probe pH-Xtra were from Luxcel Biosciences (Cork, Republic of Ireland). Bafilomycin A, CMA, nerve growth factor (NGF), collagen IV, 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), valinomycin, nigericin and other reagents were from Sigma-Aldrich. Endo-Porter was from Gene Tools, LLC (Philomath, OR). Lipofectamine 2000, OptiMEM I, Fluo-4 AM, bis-(1,3-diethylthiobarbituric acid) trimethine oxonol (DiSBAC2(3)), tetramethyl rhodamine methyl ester (TMRM), 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), Hoechst 33342, 5-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, diAM (carboxy-H2DCFDA) and Image-iT LIVE reactive oxygen species (ROS) detection kit were from Invitrogen Life Technologies (Carlsbad, CA and Dun Laoghaire, Republic of Ireland). Camptothecin, 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ) and 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzotiazepin-2(3H)-one (CGP37157) were from Tocris (Bristol, UK). Plasticware was from Sarstedt (Wexford, Republic of Ireland), MatTek (Ashland, MA) and Greiner Bio One (Frickenhausen, Germany). The peptide caloxin 1C2 (TAWSEVLDLLRRGGGSK-amide) was from GenScript (Piscataway, NJ). The mitochondria-targeted version of GFP-tagged Ca2+ sensor Case12, mitoCase12 [30, 31, 32] was from Evrogen JSC (Moscow, Russia). The GFP-based plasmid encoding the mitochondrial pH sensor mtAlpHi [33] was kindly provided by Prof. Tullio Pozzan (University of Padua, Italy). Antibodies were: polyclonal anti-LC3A/B from Cell Signaling Technology (Danvers, MA), rabbit monoclonal anti-Smac/DIABLO from Novus Biologicals (Littleton, CO), mouse monoclonal anti-tubulin from Sigma, goat polyclonal anti-rabbit and anti-mouse IRDye 800CW from LI-COR Biosciences (Lincoln, NE), donkey anti-rabbit Cy3-conjugated from Jackson ImmunoResearch Laboratory (West Grove, PA).

Cell culture

PC12 cells were cultured in RPMI 1640 medium supplemented with 2 mM l-glutamine, 10% horse serum (HS), 5% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin (P/S) in an atmosphere containing 5% CO2. For the O2 and ATP measurements, the cells were seeded at 5 × 104 cells/well into 96-well plates (Sarstedt) coated with 0.01% collagen IV, and differentiated for 3–5 days in RPMI supplemented with 1% HS, P/S, 100 ng/ml NGF. For live cell imaging, PC12 cells were differentiated on glass bottom mini-dishes (MatTek) coated with a mixture of collagen IV (0.007%) and poly-d-lysine (0.003%).

SH-SY5Y cells were cultured in DMEM supplemented with 10% FBS, 2 mM l-glutamine and P/S and differentiated, as described previously [34]. Briefly, the cells were seeded at 6 × 104 cells/well in a 96-well plate coated with collagen IV, and at 3 × 104 cells/well in collagen IV/poly-d-lysine-coated glass-bottom MatTek mini-dishes [30]. Then the medium was changed to DMEM supplemented with 10% FBS and 10 μM retinoic acid, and the cells were further incubated for 5 days. After that, the medium was changed to DMEM containing 50 ng/ml brain-derived neurotropic factor (BDNF), and differentiation was continued for 7 days before the experiments.

CGN from 7-day-old rats were prepared, as described previously [35], seeded at 2 × 105 cells/well and maintained in culture in the presence of 10 μM cytosine arabinoside for 7 days prior to use.

Preparation of the cells and loading with probes

For the i O2 assay, dPC12 cells and CGN prepared in 96-well plates were loaded by incubating them for 28 h in regular medium containing 1.2 μM MitoXpress probe and 6 μM Endo-Porter transfection reagent, as described previously [28]. dSH-SY5Y cells, which are poorly loaded with the MitoXpress probe, were loaded with the cell-penetrating probe PtCPTE-CFR9 [36] by incubating them with 10 μM probe in DMEM/BDNF for 16 h. After loading, the cells were washed with fresh medium three times and used for O2 measurements.

dPC12 and dSH-SY5Y cells were transfected with mitoCase12 and mtAlpHi plasmids using lipofectamine and OptiMEM I, as per the manufacturer’s procedure. The cells were loaded with the following fluorescent indicators in OptiMEM I: 20 nM TMRM (mitochondrial membrane potential, ΔΨm), 2.5 μM Fluo-4 AM (cytosolic Ca2+), 2.5 μM JC-1 (ΔΨm), 1 μM DiSBAC2(3) (plasma membrane potential, ΔΨp) and 2.5 μM BCECF AM (cytosolic pH) for 30 min, 1 μM Hoechst 33342 (nuclear counterstain) for 5 min, and 10 μM carboxy-H2DCFDA (ROS probe) for 45 min. All AM probes were de-esterified for 15 min prior to each experiment. During the measurements, TMRM and DiSBAC2(3) probes were maintained in solution at 20 nM and 0.25 μM, respectively. In the majority of the experiments the probes were used individually. Probe combinations were used only when their spectral, spatial and functional characteristics allowed simultaneous loading and measurement. Each spectral signal was acquired in sequential laser mode with emission gates adjusted to avoid overlaps.

Experimental conditions

The experiments with dPC12 cells were carried out in the presence of NGF in serum-free DMEM buffered with 25 mM HEPES, pH 7.4 (O2 assays) and in OPTIMEM I with additional Ca2+ at 1 mM (imaging experiments). The experiments with dSH-SY5Y cells were performed in DMEM buffered with 25 mM HEPES, pH 7.4, and supplemented with BDNF. For both cell lines, most of the experiments were carried out in medium supplemented with 10 mM glucose [glucose(+) condition]. To inhibit the glycolytic pathway of ATP generation [37], the cells were incubated in serum and glucose-free medium, containing 10 mM galactose and 1 mM pyruvate [galactose(+) condition] for 3 h prior to the measurements. The measurements on CGN were carried out in buffer containing 120 mM NaCl, 3.5 mM KCl, 0.4 mM KH2PO4, 20 mM HEPES, 5 mM NaHCO3, 1.2 mM Na2SO4, 1.2 mM CaCl2, 1.2 mM MgCl2, and 15 mM glucose, pH 7.4, as described previously [38]. Conditions of treatment with various effectors (dose, timing and media) are described in the “Results

Intracellular O2 sensing assay

Typically, a standard 96-well plate containing 24 samples of dPC12 and dSH-SY5Y cells preloaded with the O2 probe in 90 μl of air-saturated medium was measured on a time-resolved fluorescence (TR-F) plate reader (Victor 2; PerkinElmer Life Science) at 37°C using 340 nm excitation and 642 nm emission filters. Each sample well was measured repeatedly every 1.3–6 min by taking two intensity readings at delay times of 30 and 70 μs and a gate time of 100 μs [29]. The plate was initially monitored for 10–20 min to allow O2 and temperature equilibrium to be reached and to obtain baseline signals. The plate was then quickly withdrawn from the reader, compounds were added to the cells (10 μl of 10× stock solution) and monitoring was resumed. Measured TR-F intensity signals for each sample well were converted into phosphorescence life-time (τ) values and plotted as time profiles. These profiles were related to i O2 concentration (μM) according to the following equation: [O2] = − 0.0027τ3 + 0.5649τ2 − 40.104τ + 972.23. This equation was obtained from the calibration of the O2 probe [39], performed in a hypoxia chamber (Coy Scientific) equilibrated at given O2 saturation levels (0–20.9% of air saturation). Normoxic 20.91% O2 in the air roughly corresponded to 200 μM O2 in solution at +37°C [40]. Control samples were incorporated as appropriate.

Measurement of ΔΨm, ΔΨp, intracellular Ca2+, pH, ATP and ROS

Intracellular pH, cytosolic and mitochondrial Ca2+, ΔΨm, ΔΨp and ROS production were measured using an Olympus FV1000 confocal laser scanning microscope under controlled conditions of CO2, humidity and temperature. The BCECF, Fluo-4, carboxy-H2DCFDA (Image-iT LIVE ROS detection kit), mitoCase12 and mtAlpHi probes were excited at 488 nm (0.5, 5, 15, 1.5 and 10% of laser power, respectively) with emission collected at 500–550 nm. TMRM and DiSBAC2(3) were excited at 543 nm (1.5 and 1% laser power) collecting the emission with a 555–600 nm filter. JC-1 probe was excited at 488 and 543 nm (1 and 5% laser power) with emission collected at 500–540 and 555–600 nm. Hoechst 33342 was excited at 405 nm (3% laser power) with emission collected at 440–480 nm. In all the experiments fluorescent and differential interference contrast (DIC) images were acquired with a 60× oil immersion objective in two planes using a 0.5 μM step and 5–120 s intervals. The resulting z-stacked images were analysed using a FV1000 viewer (Olympus), Adobe Photoshop and Illustrator software. Mitochondria within neurites (rather than cell bodies) were used in the analyses of the TMRM fluctuations, because in this case movements of the mitochondria are constrained and they are readily observable. Cellular ATP was measured using a CellTiter-Glo assay kit (Promega, Madison) on a white 96-well plate (Greiner Bio One). ROS levels were measured using a carboxy-H2DCFDA probe and fluorescence activated cell sorter (FACS) analysis (Becton–Dickinson, NJ).

Extracellular acidification assay

The rate of extracellular acidification was monitored as described previously [41]. PC12 cells were differentiated for 4–5 days under standard CO2 conditions, then the medium was replaced with unbuffered DMEM, supplemented with 1 mM sodium pyruvate and either 10 mM glucose or 10 mM galactose, pH 7.4 (pH buffer). Cells were maintained in a CO2-free incubator at 37°C for 3 h prior to measurement and then the medium was replaced with 100 μl of fresh medium containing 1 μM of pH-Xtra probe and the stimulants. The plate was then measured kinetically on the Victor 2 plate reader at 37°C for a minimum of 30 min in the TR-F mode using a europium filter set (340 ± 35 nm excitation and 615 ± 8.5 nm emission). Two TR-F intensity signals were measured at delay times of 100 and 300 μs and a measurement window of 30 μs. The readings were converted into life-time values τ = (t 1t 2)/ln(F 1/F 2), where τ is the probe fluorescence life-time, t 1, and t 2 are the two delay times, and F 1 and F 2 are the corresponding TR-F intensity signals; τ was converted into pH and H+ values [41].

Detection of autophagic flux and apoptosis

The level of autophagy was assessed by LC3 degradation using Western blot analysis [42]. Briefly, dPC12 cells were incubated under normal or starving (HBSS supplemented with 100 ng/ml NGF) conditions for 2 h and then treated with 0.25 μM Baf or CMA under starving conditions for 4 h. Whole-cell lysate proteins were separated with gradient gel electrophoresis, transferred onto a PVDF membrane and probed with anti-LC3A/B and IRDye 800CW antibodies. Immunoblotting results were analysed using the Odyssey infrared imaging system (LI-COR Biosciences).

The level of apoptosis was measured by Smac/DIABLO translocation (immunofluorescence), and caspase-3 activation (fluorescent plate reader). Immunofluorescence analysis was performed as described previously [43]. Briefly, cells treated for 2–4 h with Baf, CMA or 5 μM camptothecin were fixed with 3.7% PFA, permeabilized with 0.25% TX100, incubated with anti-Smac and stained with Cy3-conjugated secondary antibodies. Results were analysed by confocal microscopy.

Caspase-3 activation was determined using a kit from Cayman Chemicals (Ann Arbor, MI) according to the manufacturer’s protocol. Briefly, dPC12 cells were incubated with drugs as described in the “Results”, washed in assay buffer and lysed. After addition of the enzyme substrate, caspase-3 activity was measured in a 96-well plate using the Victor 2 reader at 485 nm/535 nm (fluorescence excitation/emission).

Statistics

The data were evaluated for the significance of differences using the two-tailed Student t-test. The 0.01 level of confidence was accepted as statistically significant. Plate reader data are presented as average values ± standard deviation for six to eight repeated wells (error bars on the plots). Imaging data are presented as the averages from five to ten individual cells. All the experiments were repeated three to five times to ensure consistency of the results.

Results

Bafilomycin A1 activates the respiration and induces sustained deoxygenation of neural cells

Although uncoupling of isolated mitochondria by Baf has been described [23], its effects on cell respiration have not been investigated. Using the intracellular O2 sensing technique [29], we found that exposure of dPC12 cells to 0.25 μM Baf gradually decreased the oxygenation of the cell monolayer from 140–160 μM down to 80±5 μM O2 (Fig. 1a) due to increased respiration. Maximal respiration was achieved in 50–100 min, and then it gradually decreased but still remained elevated after >5 h. The effect was dose-dependent, becoming significant at 50 nM and reaching a maximum at 0.5–0.8 μM Baf after 45 min of treatment (Fig. 1b). In the presence of mitochondrial complex III inhibitor antimycin A the effect was abolished (not shown). If Baf was subsequently removed from the medium, respiration returned to the basal level.
Fig. 1

The effect of Baf on the respiration of dPC12 cells is attributed to mitochondrial uncoupling. a As a result of sustained activation of respiration by Baf (0.25 μM), cellular O2 levels steadily decrease for 60–80 min and then remain elevated for hours. b Dose-dependent decrease in cellular O2 measured 45 min after Baf application reveals that the respiratory response reaches a maximum at 0.5–0.8 μM Baf. c Cell deoxygenation induced by Baf increases when glucose in the medium is replaced with galactose. In contrast, 0.25 μM CMA has no effect. d Complete dissipation of the acidic compartments after 30 min treatment with 0.25 μM Baf is confirmed by LysoTracker Red staining. e The intensity of the ΔΨm-sensitive probe TMRM decreases by 30–50% when the cells are incubated with 0.25 μM Baf for 30 min. f In the cells treated with Baf or CMA for 4 h under starving conditions the level of LC3 II degradation decreases due to inhibition of autophagy. DMSO was used as a negative control. In d and e representative live cell confocal images are shown. Bar 20 μm; asterisks significant differences

When the cells were treated with 0.25 μM CMA (another V-ATPase inhibitor, which does not uncouple the mitochondria), no changes in cell oxygenation and respiration were seen (Fig. 1c), while the dissipation of acidic lysosomal compartments was similar to that seen with Baf (Fig. 1d, shown for Baf). This indicates that the respiratory response to Baf is not a consequence of V-ATPase inhibition. To confirm this, we inhibited V-ATPase via the dissociation of V0 and V1 domains prior to Baf treatment by replacing glucose in the medium with galactose [44]. Galactose also dramatically reduces the glycolytic ATP production and increases OxPhos [20], thus causing a significant decrease in cellular O2. We found that in the cells preconditioned for 3–4 h on galactose, Baf induced even higher deoxygenation (Fig. 1c) signifying that the activation of O2 consumption is not related to V-ATPase integrity and activity.

Uncoupling by the classical uncoupler FCCP or the K+ ionophore valinomycin is normally associated with complete dissipation of the mitochondrial membrane potential (ΔΨm). However, treatment of dPC12 cells with 0.25 μM Baf for 30–60 min decreased the TMRM signal only by 40 ± 10% (Fig. 1e). Under these conditions a large proportion of the mitochondria underwent substantial transformation from an elongated (5 ± 3 to 0.2 ± 0.1 μm) to a more round (3 ± 2 to 0.4 ± 0.2 μm) shape. The decrease in TMRM signal reflected only changes in ΔΨm polarization, since plasma membrane potential (ΔΨp) assessed using the DiSBAC2(3) probe remained unaffected (not shown). A substantial drop in JC-1 probe fluorescence confirmed significant depolarization of ΔΨm (Supplementary Fig. S1).

Dissipation of lysosomes by Baf and CMA was coupled with significant inhibition of autophagic flux (seen as an increase in cellular LC3A/B II levels, Fig. 1f), and an increase in ROS production (Fig. 2a, b; Supplementary Fig. S2). Both inhibition of autophagy and elevation of ROS are known to activate apoptosis. We found that caspase-3 activity (marker of apoptosis) was increased by 150–200% and about 100% after 4 h of treatment with Baf and CMA, respectively (Fig. 2c). Under the same conditions, only minor changes in Smac/DIABLO location were observed (Supplementary Fig. S3).
Fig. 2

The effect of Baf on generation of ROS and apoptosis of dPC12 cells. a FACS analysis of ROS-sensitive carboxy-H2DCFDA probe fluorescence reveal an increase in ROS levels in the cells treated with Baf and CMA (both 0.25 μM) for 2 h. b Quantitative analysis of data presented in a as compared to the effect of classical ROS inducer tert-butyl hydroperoxide (TBHP, 250 μM). c Caspase-3 activity was increased in the cells treated with both V-ATPase inhibitors for 4 h; however, the effect of Baf was significantly stronger. Asterisks significant differences

The respiratory responses of dSH-SY5Y and primary CGN to Baf treatment were similar to those observed for dPC12 (Supplementary Fig. S4). We therefore concluded that Baf induces mitochondrial uncoupling and increases respiration in neuronal cells which may lead to a sustained reduction in cellular O2 levels and induction of apoptosis.

Bafilomycin A1 perturbs energy balance in neural cells

To maintain their energy status, uncoupled cells normally increase ATP production through glycolysis, thus elevating lactate production and increasing the rates of cytosolic and extracellular acidification. Inhibition of the V-ATPase activity can also contribute to both intra- and extracellular acidification due to impaired proton transport. In dPC12 cells treated with Baf for >30 min distinct acidification of the cytosol was observed, detected with the pH probe BCECF (Fig. 3a), with the distribution of BCECF showing a punctate pattern. Cells treated with CMA revealed similar changes in the intensity and distribution of BCECF. We therefore concluded that cytosol acidification by Baf is mainly due to the inhibition of V-ATPase activity.
Fig. 3

Baf activates glycolysis and reduces ATP production by OxPhos in dPC12 cells. a In the cells treated with 0.25 μM Baf and CMA for 30 min, cytosolic pH decreases. Live-cell imaging of the BCECF distribution within the cells reveals focal condensation of the probe. b Extracellular acidification rate (ECA), which is linked to the rate of glycolysis, increases in the cells treated with 0.25 μM Baf to the levels characteristic of valinomycin (Val, 0.25 μM) or FCCP (FCCP, 0.5 μM) uncoupling. CMA (0.25 μM) does not change the extracellular acidification. c, d dPC12 cells grown in galactose(+) conditions show a decrease in their ATP levels in a Baf concentration-dependent manner (c) and a time-dependent manner (d). In glucose(+) medium Baf does not affect cellular ATP levels. Inhibition of the F0F1 ATPase by oligomycin (10 μM) further reduces the ATP levels. DMSO was used as a negative control. Asterisks significant differences

Using the fluorescent extracellular acidification probe and assay [41], we found that Baf significantly increased the rate of extracellular acidification, similar to valinomycin and FCCP (Fig. 3b), whereas CMA caused no such effect. These results indicate that the activation of glycolysis in dPC12 cells is due to uncoupling rather than V-ATPase inhibition by Baf. Further analysis of bioenergetic parameters showed that in dPC12 cells grown on galactose, ATP levels were reduced by Baf in a time- and concentration-dependent manner, while under glucose(+) conditions they remained unchanged (Fig. 3c, d). In contrast, CMA did not influence ATP levels even in the absence of glycolytic ATP supply (not shown). A similar decrease in ATP upon Baf treatment in galactose(+) medium was seen in dSH-SY5Y cells (Supplementary Fig. S5). Interestingly, an additional decrease in ATP of about 20% was observed in Baf(+) dPC12 cells upon inhibition of F0F1 ATP synthase (mitochondrial complex V) with 10 μM oligomycin (Fig. 3d). This suggests that although Baf uncoupled O2 consumption from ATP production, the cells were still able to produce ATP through OxPhos, at least at <0.25 μM Baf.

To confirm this, we analysed the changes in respiration, ΔpHm and ΔΨm, induced in Baf(+) dPC12 cells by oligomycin. Normally, inhibition of ATP synthase (the main consumer of the Η+ gradient across the mitochondrial membrane) reduces O2 consumption and leads to a rapid and sustained increase in ΔpHm [45]. We observed a 10–20% decrease in the respiratory response to Baf in the cells pretreated with oligomycin (Fig. 4a). Using the mitochondrial pH probe mtAlpHi [33], we found that oligomycin transiently elevated mitochondrial pH in Baf(+) cells (Fig. 4b). Being significantly smaller than in the control, this increase suggests that complexes I–IV of the electron transport chain (ETC) generate notable H+ gradients it the mitochondria uncoupled by Baf. This result also shows that in the presence of Baf, ATP synthase still works in direct mode utilising H+ gradients for ATP production. On the other hand, after oligomycin addition, the intensity of TMRM in Baf(+) cells gradually decreased (Fig. 4c), indicating that the complex V also participates in the maintenance of ΔΨm acting as an ATPase.
Fig. 4

Baf reduces ΔpHm and ΔΨm in dPC12 cells. a Inhibition of the F0F1 ATPase with oligomycin (10 μM) decreases Baf-specific cell deoxygenation by 10–20%. b Oligomycin treatment significantly elevates the fluorescence of the mtAlpHi probe in control cells, indicating a sustained matrix alkalinization. In Baf(+) cells the increase in ΔpH is lower and not sustainable. c TMRM profiles show a gradual decrease in probe fluorescence in Baf(+) cells upon addition of oligomycin. d Uncoupling with 0.5 μM FCCP causes a drop in TMRM and mtAlpHi fluorescence in Baf(+) cells, demonstrating a decrease in the ΔΨm and ΔpH, respectively (F0/F represents the ratio of fluorescence before and 3 min after FCCP addition). The decrease in mtAlpHi signal does not depend on Baf treatment; in contrast, the relative drop in TMRM signal in Baf(+) cells is significantly smaller than in the control. In all experiments except that shown in a, cells were preincubated with 0.25 μM Baf for 45 min prior to the addition of oligomycin or FCCP. DMSO was used as a negative control. Bars 20 μm; asterisks significant differences

Finally, we found that upon addition of FCCP to Baf(+) cells, the relative drop in mtAlpHi fluorescence was similar to that of the control (Fig. 4d), thus confirming that a large proportion of the ΔpH is retained by the mitochondria. The relative decrease in TMRM signal induced by FCCP in Baf(+) cells was significantly smaller than in the control, confirming partial depolarization of ΔΨm in Baf(+) cells (see Fig. 1e).

Taken together, these data indicate that mitochondrial uncoupling induced by Baf is associated with large perturbations in cellular metabolism and energy balance.

Bafilomycin A1 induces flickering depolarization of the mitochondria in dPC12 cells

The marked decrease in cellular TMRM signal upon Baf treatment (Fig. 1e) can be interpreted as partial depolarization of the whole mitochondrial pool of the cell. However, when analysing confocal images for spatial distribution of TMRM (ΔΨm) and mitoCase12 (mitochondrial Ca2+) within individual cells, we found a significant (25 ± 10%) decrease in their colocalization 45 min after Baf addition (Fig. 5a). Since the mitoCase12 probe has no tendency to leak (being a mitochondria-targeted protein), this result pointed to a decrease in the proportion of polarized mitochondria, rather than a more general partial depolarization. Indeed, further analysis of the TMRM signal in individual mitochondria in dPC12 cell neurites visualized by mitoCase12, revealed random, flickering depolarization, which can be seen 10 min after Baf application and lasts for several hours (Fig. 5b, c; Supplementary movie). In galactose(+) medium the flickering developed even more rapidly (within 5 min in individual cells). Although such flickering had rather high interexperiment variability complicating its detailed statistical analysis, it was clearly visible after 45-min incubation with Baf in about 15–55% of cells, and progressed to about 100% of the cell population in 1–3 h. Detailed time-lapse image analysis of cells after 1 h of Baf treatment (images taken every 0.5 s) revealed that ΔΨm flickering between the polarized and depolarized states occurred with an average period of 20 ± 10 s (Supplementary Fig. S6). Marked fluctuations in TMRM fluorescence (90 ± 5%) showed that most individual mitochondria underwent full depolarization and restoration of the ΔΨm. In control cells, transient fluctuations in TMRM signal without prominent flickering were observed in <3% of cells. Confocal images recorded at different sampling frequencies (every 5–20 s) showed that ΔΨm fluctuations were independent of illumination of the TMRM probe (which can also depolarize mitochondria upon photoactivation [46]).
Fig. 5

Baf induces flickering depolarization of the ΔΨm in dPC12 cells. a Colocalization of the TMRM and mitoCase12 probes in cells treated with Baf for 45 min decreases from 90–95% to 50–80%. b, c Large fluctuations of TMRM signals in individual mitochondria located in cell neurites and costained with mitoCase12 probe (b inset) reveal a flickering pattern of ΔΨm depolarization. The dashed line (c) shows a cross-section of representative mitochondria selected for analysis. d, e In individual mitochondria localized in neurites (d arrows), TMRM intensity periodically drops by 90 ± 5% and then returns to the basal level, while the mitoCase12 fluorescence shows 15–25% fluctuations. f Inhibition of PTP opening by CsA (2 μM) strongly increases the effect of Baf on ΔΨm depolarization. In contrast, thapsigargin (10 μM, Thaps) does not change the effect of Baf on the TMRM signal. However, the morphology of the mitochondria changes dramatically: they become large round compartments with an average diameter of 1–2 μm. g 15 min after the addition of Baf to the cells preincubated with CsA, TMRM intensity decreases to 15–50%, which is significantly different to the cells treated with Baf alone. Inhibition of F0F1 ATPase with oligomycin (10 μM, Olig) has a similar effect. Antimycin A completely depolarizes the mitochondria. Thapsigargin strongly increases variability of the response to Baf. All preincubations were done for 30 min. DMSO was used as a negative control. Bar 20 μm; asterisks significant differences

We also observed fluctuations in mitoCase12 fluorescence of around 10–25% (Fig. 5d, e), mostly in-phase with the changes in ΔΨm. This synchronism was to be expected, since mitochondrial Ca2+ uptake can depolarize ΔΨm [47, 48]. In turn, ΔΨm depolarization inhibits Ca2+ influx through the electrogenic mitochondrial Ca2+ uniporter [49] and shifts the balance of the mitochondrial Ca2+ fluxes towards Ca2+ extrusion. Since the endoplasmic reticulum (ER) is considered to be the main contributor to mitochondrial Ca2+ fluxes [50, 51], we studied the role of this compartment in the Baf-specific flickering. Figure 5f shows that inhibition of sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) with thapsigargin noticeably changed the morphology of mitochondria in dPC12 cells treated with Baf. After 1 h of thapsigargin/30 min of Baf treatment, the mitochondria were transformed into large round structures (1.5–3.5 μm in diameter), which could be seen on the DIC images. TMRM staining remained intense (Fig. 5f, g) and became more diffuse, whereas the amplitude and frequency of flickering decreased. When Baf was applied to cells pretreated with thapsigargin for 30 min, this effect started to develop within 7–10 min (Supplementary Fig. S7). Thapsigargin alone did not affect the morphology and polarization of the mitochondria. These results demonstrate the importance of the ER in the development of stochastic ΔΨm fluctuations and in the maintenance of mitochondrial function.

One of the mechanisms proposed for Ca2+-mediated fluctuations in ΔΨm is transient opening of the PTP [52]. Similarly, PTP opening followed by ΔΨm depolarization has been described for mitochondria overloaded with K+ [53]. To investigate the contribution of PTP to the ΔΨm flickering, we applied Baf to dPC12 cells pretreated with cyclosporine A (CsA, 2 μM), which binds cyclophilin D and prevents the formation of PTP. CsA itself did not affect the polarization of mitochondria, but dramatically increased the effect of Baf on the ΔΨm (Fig. 5f, g). Monitored after 1 h of the double treatment, the majority of cells lost TMRM staining, and only a minor population of the mitochondria revealed the characteristic flickering of ΔΨm with low TMRM intensity. When Baf was applied to cells pretreated with CsA for 30 min, it triggered depolarization and flickering of the ΔΨm within minutes, whereas after 15 min TMRM staining decreased by 70 ± 20% (Fig. 5g). The effect of CsA on ΔΨm depolarization by Baf was dose-dependent and barely visible at CsA concentrations <0.75 μM. Finally, CsA did not inhibit activation of caspase-3 by Baf (data not shown).

Since ΔΨm and F0F1 ATP synthase activity are reciprocally regulated, the latter can modulate ΔΨm flickering. We inhibited ATP synthase with oligomycin and observed a fast progressive decrease in TMRM fluorescence after Baf addition, with only minor reductions in flickering. When the mitochondrial complex III was inhibited by antimycin A, mitochondria lost ΔΨm within 5–7 min after Baf addition without any flickering (not shown).

Overall, we concluded that the characteristic random ΔΨm flickering of individual mitochondria in PC12 cells is associated with Baf uncoupling.

The interplay between bafilomycin A1 and Ca2+ in the regulation of respiration

In dPC12 cells treated with 0.25 μM Baf for 30 min or longer, we observed a dramatic elevation of cytosolic Ca2+, seen as an increase of 140 ± 40% in Fluo-4 fluorescence (Fig. 6a). In approximately 30% of the cells, Fluo-4 fluorescence was distributed diffusely throughout the cytoplasm, including neurites. More than 50% of the cells had bright punctate Fluo-4 staining with poorly identifiable localization. Over time, the distribution of cytosolic Ca2+ became more uneven and punctate. A similar effect was observed in dSH-SY5Y and CGN cells (not shown).
Fig. 6

The interplay between Baf and Ca2+ in dPC12 cell. a Cytosolic Ca2+ levels increase dramatically after 45–60 min of treatment with 0.25 μM Baf, as detected with the Fluo-4 probe. b Uncoupling with 0.5 μM FCCP causes a dramatic drop in mitoCase12 fluorescence in Baf(+) cells, indicating a deep decrease in mitochondrial Ca2+, similar to that seen in the control. c The effect of Baf on cell respiration is abolished by increasing the Ca2+ buffering capacity of the cytosol with 25 μM BAPTA-AM or by inhibiting the SERCA with 10 μM thapsigargin. The respiratory response is not changed under extracellular Ca2+-free conditions, or upon inhibition of plasma membrane Ca2+-ATPase with caloxin 1C2 (100 μM). It is not significantly downregulated by the inhibition of mitochondrial Na+/Ca2+ exchanger with CGP37157 (10 μM). DMSO was used as a negative control. Bars 20 μm; asterisks significant differences

Since the ΔΨp remained relatively unchanged upon Baf treatment, Ca2+ influx through voltage-gated calcium channels was ruled out. Therefore, the increase in cytosolic Ca2+ was provided by intracellular stores. The two candidate organelles affected by Baf directly are the acidic compartments and the mitochondria. Indeed, the impairment of V-ATPase activity dissipates the H+ gradients across the membrane and abolishes the deposition of Ca2+ into acidic stores. On the other hand, it is known that partial depolarization of ΔΨm and decrease in matrix pH can inhibit Ca2+ influx into the mitochondria and activate Ca2+ release through the mitochondrial Na+/Ca2+ exchanger (mNCX) [49, 54]. In assessing this, we found that the pool of acidic compartments is the main contributor to the elevation of cytosolic Ca2+, because the inhibition of V-ATPase with CMA caused a similar increase in Fluo-4 fluorescence (not shown). To estimate the contribution of mitochondria to sustained elevation of cytosolic Ca2+ and the long-term effect on mitochondrial Ca2+ levels, we preincubated dPC12 cells with Baf for 1–2 h and then treated with FCCP (0.5 μM), which is known to induce a drop in the mitochondrial Ca2+ [55]. A large and rapid decrease in mitoCase12 fluorescence was observed irrespective of Baf pretreatment (Fig. 6b), suggesting that mitochondria retained a large proportion of Ca2+ after the prolonged exposure of cells to Baf.

High cytosolic Ca2+ increases Ca2+ fluxes and intercompartmental Ca2+ exchange, thus regulating cell metabolism and particularly OxPhos [56]. Considering the persistent fluctuations in mitochondrial Ca2+ (Fig. 5d, e), we examined the role of Ca2+ fluxes in the respiratory response to Baf. The increase in respiration was completely abolished by blocking cytosolic Ca2+ fluctuations with the intracellular chelator BAPTA (Fig. 6c) or by inhibiting the SERCA with thapsigargin (10–15 μM). A similar effect was observed when the SERCA was inhibited by BHQ (50 μM). The effect of Baf was partially decreased by CGP37157 (inhibitor of the mNCX, 10–15 μM). In contrast, neither the removal of extracellular Ca2+ with EGTA nor the inhibition of plasma membrane Ca2+-ATPase with 100 μM caloxin 1C2 [57] affected the respiratory response to Baf. This reveals that respiration is increased by a mechanism independent of Ca2+ fluxes across the plasma membrane.

Taken together, the respiratory response to Baf, although attributed to mitochondrial uncoupling, is strongly regulated by the cytosolic Ca2+ fluxes and the Ca2+ buffering capacity of cellular compartments, particularly the ER which is the main partner for Ca2+ exchange with mitochondria.

Bafilomycin A1 increases cell susceptibility to excitatory stimulation

Mitochondrial uncoupling increases the risk of energy crisis upon cell excitation, while for the cells lacking acidic compartments and overloaded with Ca2+ the risk increases further. We investigated how Baf affects respiratory responses to excitatory stimuli.

Depolarization of the ΔΨp by high K+ triggers a rapid transient decrease in the O2 level and substantial elevation of ATP level in dPC12 cells, which reaches a maximum in 2–5 min after K+ addition [28]. Preincubation with Baf significantly increased the respiratory response to K+ (Fig. 7a, b). This increase was further augmented by thapsigargin. Under extracellular Ca2+-free conditions the response of Baf-treated cells to K+ was abolished (Fig. 7b). While measuring the changes in ATP levels induced by high K+, we found that in Baf-treated cells grown on glucose the characteristic increase in ATP was partially inhibited (Fig. 7c), whereas under galactose(+) conditions the addition of K+ caused a significant drop in cellular ATP. Pretreatment with CMA did not change the respiratory response and slightly reduced the ATP response to K+. For comparison, valinomycin (0.25 μM) did not affect the ATP response to K+ in glucose(+) medium, while under galactose(+) conditions it dramatically reduced ATP irrespective of K+ addition.
Fig. 7

Baf increases susceptibility of dPC12 to excitatory stimulation. a Pretreatment with 0.25 μM Baf dramatically increases the respiratory response to ΔΨp depolarization by high K+. The response is not reduced by the SERCA inhibitor thapsigargin. The dashed line shows the level of deoxygenation induced by K+ in the Baf(−) cells treated with thapsigargin. b In Ca2+-free medium Baf(+) cells do not respond to high K+ and rapidly loose their respiratory activity. c Pretreatment with Baf (25 μM, 30 min) in glucose(+) medium reduces elevation of ATP in response to ΔΨp depolarization by high K+, whereas in galactose(+) medium K+ stimulation strongly decreases cellular ATP. The effect of CMA (0.25 μM) on the ATP response to K+ is less pronounced. Valinomycin (Val, 0.25 μM) in galactose(+) conditions reduces the ATP by >90%, irrespective of K+ treatment. d Pretreatment of the cells with 25 μM Baf for 30 min amplifies the dose-dependent response to glutamate (5–20 mM), while CMA does not affect the response to glutamate. e Relative decrease in cellular ATP (measured 20 h after glutamate treatment) reveals a negative effect of Baf on the viability of dPC12 cells, exposed to glutamate. DMSO was used as a negative control. Asterisks significant differences

Glutamate was shown to induce cytotoxicity in PC12 cells [58]. We applied 5, 10 and 20 mM glutamate to Baf(+) and Baf(−) dPC12 cells and found that Baf significantly increased the respiratory response to glutamate (Fig. 7d). Moreover, Baf markedly reduced the viability of the cells, treated with glutamate (Fig. 7e); determined by measuring total cellular ATP levels 20 h after glutamate application, cell viability decreased with the elevation of glutamate. These effects were not observed in the cells treated with CMA.

These results demonstrate that susceptibility of Baf(+) dPC12 cells to excitatory stimulation increases significantly, while their energy demand upon excitation is not met by the ATP production.

Discussion

Known for two decades as an effective inhibitor of V-ATPases [1], Baf has been recently recognized also as a K+ ionophore with uncoupling potency on isolated mitochondria [23]. The key finding of this work was the sustained activation of respiration of intact neural cells leading to decreased cellular O2. The respiratory response to Baf developed gradually over 50–100 min, and then persisted for many hours (Fig. 1). The response became detectable at ≥50 nM, which is in the range of Baf concentrations found in the literature (from subnanomolar to 10 μM [18, 22]). The ability of Baf(+) cells to sustain uncoupling and maintain elevated respiration for many hours without serious change in viability arises from resultant alterations in certain bioenergetic parameters. In particular, free cytosolic Ca2+ was strongly elevated as a consequence of V-ATPase inhibition, ΔΨm was partially reduced, whereas mitochondrial Ca2+ and ΔpHm were moderately decreased, thus allowing ATP production by the OxPhos. However, in the absence of glycolytic ATP supply, the total energy level in Baf(+) cells gradually decreased (Fig. 3c) as a consequence of increased ATP expenditure and a transient reversal of F0F1 ATP synthase activity. The latter process correlated with large continuous fluctuations of the ΔΨm in individual mitochondria upon Baf treatment (Fig. 5, Supplementary Fig. S6, Supplementary movie), which were not observed in the cells treated with the traditional uncoupler FCCP or the K+ ionophore valinomycin.

Orchestrated by Baf, gradual depolarization of the ΔΨm developed due to progressive establishment of a new ion and energy state, which was not lethal to dPC12 cells (for at least 6 h). This process was accompanied by an increased proportion of mitochondria that exhibit flickering (i.e. transiently depolarized). Indeed, live imaging of the Baf-treated cells demonstrated that stochastically flickering TMRM signals were colocalized with the mitochondria-targeted calcium indicator mitoCase12 only in 50–80% of mitochondria (Fig. 5a), in contrast to 90–95% in control cells. The degree of observed colocalization represents the probability of being in the polarized state for each individual mitochondrion at a given time point.

It is known that in response to ΔΨm depolarization by FCCP, F0F1 ATP synthase reverts to an ATPase consuming ATP to restore ΔΨm, especially when glycolytic ATP supply is inhibited [59, 60]. Our data suggest that in Baf-treated dPC12 cells F0F1 ATP synthase works in both direct and reverse mode, depending on the ΔΨm of individual mitochondria and the whole mitochondrial network. ATP synthase activity was evident, since oligomycin partially inhibited the respiratory response to Baf and induced transient ETC-mediated alkalization of the mitochondrial matrix (Fig. 4b). When the mitochondrion was depolarized by Baf, F0F1 ATP synthase switched to the reverse mode and consumed ATP for ΔΨm restoration.

In Baf(+) dPC12 cells, the rate of glycolysis was increased to meet energy expenditure (Fig. 3), including the energy spent on ΔΨm restoration by F0F1 ATP synthase. As a result, total cellular ATP levels remained practically unchanged and ΔΨm decreased only partially. However, when complex V was inhibited by oligomycin and could not utilize ATP, the ΔΨm decreased faster (Fig. 4c). If the glycolytic ATP supply was cut off, total cellular ATP decreased progressively. A further decrease in ATP upon oligomycin treatment in Baf(+) cells grown on galactose was somewhat surprising (Fig. 3d); it suggests that Baf-treated cells still produced ATP by OxPhos. The ability of the cells to maintain ΔΨm flickering in galactose(+) medium (data not shown) supports this conclusion. Interestingly, inhibition of the ETC complex III, but not complex V, abolished the flickering and rapidly depolarized the mitochondria (Fig. 5g). This result suggests that the activity of F0F1 ATP synthase is mediated by ΔΨm flickering, rather than drives it.

The phenomenon of flickering mitochondrial depolarization is known. ΔΨm may be modulated by the photoactivation of TMRM described for the tetramethylrhodamine probes [61]. It has been shown that spontaneous depolarization of individual mitochondria isolated from heart tissue and the decrease in ΔΨm in the population of mitochondria are caused by the repeated opening of the PTP due to light-induced generation of free radicals by TMRE probe [62]. Similar results have been demonstrated for intact HeLa cells loaded with TMRM [46]. In contrast, in cultured forebrain neurons the low-amplitude spontaneous fluctuations in ΔΨm of individual mitochondria were detected with TMRM and JC-1 probes, and were not related to light exposure [63]. The authors concluded that such ΔΨm oscillations reflect the alternation between active and inactive states of OxPhos. In our study, we did not observe significant light-induced oscillations or a gradual decrease in TMRM signal in intact cells upon light exposure.

PTP opening has been suggested to be the mechanism involved in transient depolarizations of ΔΨm [52, 53]. We showed that inhibition of PTP opening by CsA strongly increased the depolarization of mitochondria by Baf (Fig. 5, Supplementary Fig. S7), and did not prevent or decrease ΔΨm flickering. Instead, the oscillations begin sooner than with Baf alone. This indicates that the initiation of flickering does not require PTP opening and that PTP opening is involved in the maintenance of mitochondrial polarization and function under conditions of impaired K+, H+ and Ca2+ balance. It is possible that PTP opening is involved in the release of excessive osmotic pressure from the mitochondrial matrix, which is generated through K+ ionophore activity of Baf. Regulation of PTP opening by K+ influx into the matrix is discussed in [53]. Therefore, PTP opening may serve to restore the shape and function of the mitochondria. When this process is inhibited by CsA, the ΔΨm depolarizes more quickly. On the other hand, the fact that ΔΨm flickering occurs in the presence of CsA, suggests that a different mechanism may also be involved in the stochastic depolarization and repolarization of mitochondria.

Ca2+ is an important regulator of mitochondrial function [64, 65]. To transport Ca2+ into the matrix, the mitochondrial uniporter requires polarized ΔΨm [66] and a high concentration of Ca2+ in the vicinity of the mitochondria [67]. In Baf(+) cells both conditions are provided: the ΔΨm is retained by a considerable proportion of mitochondria, while cytosolic Ca2+ is strongly and steadily elevated due to the dissipation of H+ gradients in the V-ATPase-regulated acidic Ca2+ stores. However, our results suggest that the effect of Ca2+ on the Baf-dependent increase in respiration is mediated by the ER, which is one of the main players in the Ca2+ turnover and a partner of the mitochondria in Ca2+ exchange [50, 51]. We hypothesize that high cytosolic Ca2+ could randomly activate Ca2+-dependent Ca2+ release from the ER network surrounding the mitochondria. In turn, local increases in Ca2+ could activate the mitochondrial uniporter and trigger Ca2+ entry to the mitochondria. An elevation in Ca2+ transiently depolarizes ΔΨm [63] and causes release of the mitochondrial Ca2+, which is then again buffered by the ER. This is supported by the observation that thapsigargin and BHQ, which inhibit SERCA and prevent Ca2+ crosstalk between the ER and mitochondria, abolish the respiratory effect of Baf (Fig. 6). Moreover, when SERCA is inhibited, Baf induces dramatic changes in the mitochondrial morphology and the mode of ΔΨm flickering (Fig. 5, Supplementary Fig. S7). A similar effect on the respiratory response to Baf can be achieved with the Ca2+ chelator BAPTA, which buffers Ca2+ fluxes in the cytosol and prevents intercompartmental Ca2+ exchange. In contrast, extracellular Ca2+ does not seem to be involved in the regulation of the respiratory response to Baf.

K+ balance is also important for the maintenance of ΔΨm, mitochondrial integrity and function. It is controlled by the Ca2+-dependent (K Ca + ) and ATP-dependent (KATP) K+ channels responsible for influx, and by the K+/H+ exchanger which performs K+ efflux from the matrix [53]. Despite the difficulties in the estimation of K+ fluxes across the inner mitochondrial membrane [68, 69], it is considered that the K+ efflux pathway exceeds influx, and the K+ concentration in the matrix is lower than in the cytoplasm [53]. An increase in matrix K+ leads to depolarization and swelling of the mitochondria. This can be observed in cells treated with valinomycin, which transports K+ into the matrix mimicking the activation of mitochondrial K Ca + and K ATP + channels. Characteristic morphological changes of the mitochondria from an elongated to a more round shape suggest that K+ transport by Baf may directly affect mitochondrial function and contribute to ΔΨm depolarization and flickering by increasing matrix volume, causing swelling and physical damage to the mitochondria [53]. The dissipation of lysosomes, which are normally responsible for mitochondrial turnover [70], may also contribute to the unusual bioenergetic status of Baf(+) cells.

Inhibition of autophagy resulting from lysosomal dysfunction [71] does not seem to be affected by Baf uncoupling, since CMA causes a similar accumulation of LC3 II (Fig. 1f). Our data suggest that increased ROS production is caused by inhibition of V-ATPase rather than mitochondrial uncoupling (Fig. 2, Supplementary Fig. S2). However, caspase-3, the key enzyme in the apoptotic pathway, is activated by Baf to a larger degree than by CMA, suggesting that an overload of the mitochondria with K+ and frequent ΔΨm depolarization contribute to the effect of Baf on apoptosis. So far, apoptosis has been considered mostly to result from V-ATPase inhibition and lysosomal dysfunction [15, 16].

Our data also show that neuronal cells uncoupled by Baf, overloaded with cytosolic Ca2+ and lacking functional acidic compartments become more susceptible to excitation. Stimulation with glutamate and depolarization of ΔΨp by high K+ induce significantly stronger respiratory responses in Baf-treated cells (Fig. 7), and such amplified responses occur in the cells devoid of neurotransmission [72]. Increased susceptibility to excitatory stimulation and the evidence that increased energy demand upon excitation is not met by ATP production (Fig. 7) may have important physiological implications. Another interesting area for further investigation is the increased hypoxia in the cells uncoupled by Baf. We show here that upon Baf treatment at ambient O2 (200 μM in extracellular medium), the concentration of O2 in dense cell monolayers drops from about 150 μM to 100 μM and remains at this level for hours (Fig. 1). Considering the high O2 consumption by excitable tissues and limited O2 supply in solid tumours, we expect that Baf treatment may cause deep cell/tissue deoxygenation in vivo. Therefore, regulatory mechanisms modulated by hypoxia may be involved in cellular responses to Baf including apoptosis and HIF-1α stabilization. So far these responses have been attributed mostly to V-ATPase inhibition by this multifunctional drug.

Notes

Acknowledgments

This material is based upon work supported by the Science Foundation Ireland under Grant No. 07/IN.1/B1804. The authors thank Dr. M. Ward for assistance in the experiments with cerebellar granule neurons, Dr. C. Favre for help with FACS analysis, Prof. T. Pozzan for providing the mtAlpHi plasmid, the Department of Anatomy, UCC, for access to the confocal imaging facility and Dr. J. Hynes for the help with manuscript correction.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Supplementary material

Flickering depolarization of TMRM signal (red) in individual mitochondria visualized by mitoCase12 (green) (MPEG 4950 kb)

18_2010_502_MOESM2_ESM.eps (8.8 mb)
Decrease in JC-1 fluorescence and probe redistribution upon treatment with Baf (0.25 μM) indicates substantial loss in ΔΨm by PC12 cells (green nonaggregated JC-1, red J-aggregates (localized predominantly in neurites and showing highly polarized mitochondria; bar 20 μm)
18_2010_502_MOESM3_ESM.eps (3.6 mb)
Effect of Baf on generation of ROS in dPC12 cells. a Live cell confocal images of ROS-sensitive carboxy-H2DCFDA probe reveal increase in ROS levels in the cells treated with Baf and CMA (both 0.25 μM) for 2 h. b Quantitative analysis of the data presented in a as compared to the effect on classical ROS inductor tert-butyl hydroperoxide (TBHP, 250 μM). Bar 20 μm; asterisk significant difference
18_2010_502_MOESM4_ESM.eps (2.8 mb)
Effect of Baf on Smac/DIABLO release from the mitochondria of dPC12 cells. Cells were treated with Baf, CMA (both at 0.25 μM) or DMSO for 4 h, fixed, permeabilized and analysed using anti-Smac/DIABLO antibodies. Upper panel: confocal imaging shows that Smac/DIABLO has a more diffuse distribution than either the control or CMA-treated cells; however the difference is minor. Lower panel: typical profiles of the Smac/DIABLO distribution in the cells. Each image represents the Z-stack of two sections. DAPI was used for counterstaining. Bar 20 μm
18_2010_502_MOESM5_ESM.eps (471 kb)
Levels of sustained oxygenation induced by Baf (0.25 μM, 30 min) in the monolayer of dSH-SY5Y and primary cerebellar granule neurons. The effect of Baf is similar to that found in dPC12 cells. CMA (0.25 μM) does not affect the respiration in dSH-SY5Y cells, whereas valinomycin (0.25 μM) increases respiration only transiently. DMSO was used as a negative control. Asterisks significant difference
18_2010_502_MOESM6_ESM.eps (443 kb)
Changes in ATP levels in differentiated SH-SY5Y cells treated with Baf, mitochondrial uncouplers and inhibitor of the electron transport chain. In galactose(+) medium the ATP level strongly decreases upon Baf (0.25 μM), valinomycin (0.25 μM), FCCP (0.5 μM) and antimycin A (10 μM) treatment. CMA (0.25 μM) does not change the ATP level. DMSO was used as a negative control. Asterisk significant difference
18_2010_502_MOESM7_ESM.eps (855 kb)
Traces of ΔΨm flickering in individual mitochondria of dPC12 cells treated with 0.25 μM Baf for 1 h. Recorded every 0.5 s, TMRM fluorescence reveals stochastic depolarizations and repolarizations of the ΔΨm at a frequency of 20 ± 10 s
18_2010_502_MOESM8_ESM.eps (21.7 mb)
Effects of cyclosporine A (CsA) and thapsigargin (Thaps) on ΔΨm depolarization induced by Baf. a Confocal real time images of dPC12 cells pretreated for 30 min with 10 μM Thaps, 2 μM CsA or DMSO (negative control) and then treated with 0.25 μM Baf. b Changes in normalized TMRM fluorescence of the representative cells shown in a show that pretreatment with CsA significantly increased the effect of Baf. Bar 20 μm

References

  1. 1.
    Bowman EJ, Siebers A, Altendorf K (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85:7972–7976CrossRefPubMedGoogle Scholar
  2. 2.
    Nishi T, Forgac M (2002) The vacuolar (H+)-ATPases – nature’s most versatile proton pumps. Nat Rev 3:94–103CrossRefGoogle Scholar
  3. 3.
    Beyenbach KW, Wieczorek H (2006) The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J Exp Biol 209:577–589CrossRefPubMedGoogle Scholar
  4. 4.
    Shin L, Basi N, Jeremic A, Lee JS, Cho WJ, Chen Z, Abu-Hamdah R, Oupicky D, Jena BP (2009) Involvement of vH(+)-ATPase in synaptic vesicle swelling. J Neurosci Res 88:95–101CrossRefGoogle Scholar
  5. 5.
    Huss M, Wieczorek H (2009) Inhibitors of V-ATPases: old and new players. J Exp Biol 212:341–346CrossRefPubMedGoogle Scholar
  6. 6.
    Werner G, Hagenmaier H, Drautz H, Baumgartner A, Zahner H (1984) Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo) 37:110–117Google Scholar
  7. 7.
    Bowman EJ, Graham LA, Stevens TH, Bowman BJ (2004) The bafilomycin/concanamycin binding site in subunit c of the V-ATPases from Neurospora crassa and Saccharomyces cerevisiae. J Biol Chem 279:33131–33138CrossRefPubMedGoogle Scholar
  8. 8.
    Bowman BJ, Bowman EJ (2002) Mutations in subunit C of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site. J Biol Chem 277:3965–3972CrossRefPubMedGoogle Scholar
  9. 9.
    Kane PM (2006) The where, when, and how of organelle acidification by the yeast vacuolar H+-ATPase. Microbiol Mol Biol Rev 70:177–191CrossRefPubMedGoogle Scholar
  10. 10.
    Gonzalez A, Pfeiffer F, Schmid A, Schulz I (1998) Effect of intracellular pH on acetylcholine-induced Ca2+ waves in mouse pancreatic acinar cells. Am J Physiol 275:C810–C817PubMedGoogle Scholar
  11. 11.
    Gerasimenko JV, Lur G, Sherwood MW, Ebisui E, Tepikin AV, Mikoshiba K, Gerasimenko OV, Petersen OH (2009) Pancreatic protease activation by alcohol metabolite depends on Ca2+ release via acid store IP3 receptors. Proc Natl Acad Sci U S A 106:10758–10763PubMedGoogle Scholar
  12. 12.
    Lopez JJ, Camello-Almaraz C, Pariente JA, Salido GM, Rosado JA (2005) Ca2+ accumulation into acidic organelles mediated by Ca2+- and vacuolar H+-ATPases in human platelets. Biochem J 390:243–252CrossRefPubMedGoogle Scholar
  13. 13.
    Petersen OH, Tepikin AV (2008) Polarized calcium signaling in exocrine gland cells. Annu Rev Physiol 70:273–299CrossRefPubMedGoogle Scholar
  14. 14.
    Crompton M (2000) Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529(Pt 1):11–21CrossRefPubMedGoogle Scholar
  15. 15.
    Wu YC, Wu WK, Li Y, Yu L, Li ZJ, Wong CC, Li HT, Sung JJ, Cho CH (2009) Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem Biophys Res Commun 382:451–456CrossRefPubMedGoogle Scholar
  16. 16.
    Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025–1040CrossRefPubMedGoogle Scholar
  17. 17.
    Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23:33–42CrossRefPubMedGoogle Scholar
  18. 18.
    Lim JH, Park JW, Kim MS, Park SK, Johnson RS, Chun YS (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Mol Pharmacol 70:1856–1865CrossRefPubMedGoogle Scholar
  19. 19.
    Semenza GL (2006) Baffled by bafilomycin: an anticancer agent that induces hypoxia-inducible factor-1alpha expression. Mol Pharmacol 70:1841–1843CrossRefPubMedGoogle Scholar
  20. 20.
    Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS, Chun YS (2007) ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1. Mol Pharmacol 71:942–948CrossRefPubMedGoogle Scholar
  21. 21.
    Hong J, Nakano Y, Yokomakura A, Ishihara K, Kim S, Kang YS, Ohuchi K (2006) Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells. J Pharmacol Exp Ther 319:672–681CrossRefPubMedGoogle Scholar
  22. 22.
    Shacka JJ, Klocke BJ, Shibata M, Uchiyama Y, Datta G, Schmidt RE, Roth KA (2006) Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol Pharmacol 69:1125–1136CrossRefPubMedGoogle Scholar
  23. 23.
    Teplova VV, Tonshin AA, Grigoriev PA, Saris NE, Salkinoja-Salonen MS (2007) Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J Bioenerg Biomembr 39:321–329CrossRefPubMedGoogle Scholar
  24. 24.
    Dykens JA, Will Y (2007) The significance of mitochondrial toxicity testing in drug development. Drug Discov Today 12:777–785CrossRefPubMedGoogle Scholar
  25. 25.
    Liu H, Felix R, Gurnett CA, De Waard M, Witcher DR, Campbell KP (1996) Expression and subunit interaction of voltage-dependent Ca2+ channels in PC12 cells. J Neurosci 16:7557–7565PubMedGoogle Scholar
  26. 26.
    Shafer TJ, Atchison WD (1991) Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12:473–492PubMedGoogle Scholar
  27. 27.
    Reynolds EE, Melega WP, Howard BD (1982) Adenosine 5′-triphosphate independent secretion from PC12 pheochromocytoma cells. Biochemistry 21:4795–4799CrossRefPubMedGoogle Scholar
  28. 28.
    Zhdanov AV, Ward MW, Prehn JH, Papkovsky DB (2008) Dynamics of intracellular oxygen in PC12 cells upon stimulation of neurotransmission. J Biol Chem 283:5650–5661CrossRefPubMedGoogle Scholar
  29. 29.
    O’Riordan TC, Zhdanov AV, Ponomarev GV, Papkovsky DB (2007) Analysis of intracellular oxygen and metabolic responses of mammalian cells by time-resolved fluorometry. Anal Chem 79:9414–9419CrossRefPubMedGoogle Scholar
  30. 30.
    Zhdanov AV, Ward MW, Taylor CT, Souslova EA, Chudakov DM, Prehn JH, Papkovsky DB (2010) Extracellular calcium depletion transiently elevates oxygen consumption in neurosecretory PC12 cells through activation of mitochondrial Na(+)/Ca(2+) exchange. Biochim Biophys Acta 1797:1627–1637CrossRefPubMedGoogle Scholar
  31. 31.
    Rizzuto R, Brini M, Pizzo P, Murgia M, Pozzan T (1995) Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr Biol 5:635–642CrossRefPubMedGoogle Scholar
  32. 32.
    Rizzuto R, Nakase H, Darras B, Francke U, Fabrizi GM, Mengel T, Walsh F, Kadenbach B, DiMauro S, Schon EA (1989) A gene specifying subunit VIII of human cytochrome c oxidase is localized to chromosome 11 and is expressed in both muscle and non-muscle tissues. J Biol Chem 264:10595–10600PubMedGoogle Scholar
  33. 33.
    Abad MF, Di Benedetto G, Magalhaes PJ, Filippin L, Pozzan T (2004) Mitochondrial pH monitored by a new engineered green fluorescent protein mutant. J Biol Chem 279:11521–11529CrossRefPubMedGoogle Scholar
  34. 34.
    Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991–1003CrossRefPubMedGoogle Scholar
  35. 35.
    Ward MW, Rego AC, Frenguelli BG, Nicholls DG (2000) Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 20:7208–7219PubMedGoogle Scholar
  36. 36.
    Dmitriev RI, Zhdanov AV, Ponomarev GV, Yashunski DV, Papkovsky DB (2010) Intracellular oxygen-sensitive phosphorescent probes based on cell-penetrating peptides. Anal Biochem 398(1):24–33CrossRefPubMedGoogle Scholar
  37. 37.
    Marroquin LD, Hynes J, Dykens JA, Jamieson JD, Will Y (2007) Circumventing the crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97:539–547CrossRefPubMedGoogle Scholar
  38. 38.
    Nicholls DG (2006) Simultaneous monitoring of ionophore- and inhibitor-mediated plasma and mitochondrial membrane potential changes in cultured neurons. J Biol Chem 281:14864–14874CrossRefPubMedGoogle Scholar
  39. 39.
    Zhdanov AV, Ogurtsov VI, Taylor CT, Papkovsky DB (2010) Monitoring of cell oxygenation and responses to metabolic stimulation by intracellular oxygen sensing technique. Integr Biol. doi: 10.1039/C0IB00021C
  40. 40.
    Tuckerman JR, Zhao Y, Hewitson KS, Tian YM, Pugh CW, Ratcliffe PJ, Mole DR (2004) Determination and comparison of specific activity of the HIF-prolyl hydroxylases. FEBS Lett 576:145–150CrossRefPubMedGoogle Scholar
  41. 41.
    Hynes J, O’Riordan TC, Zhdanov AV, Uray G, Will Y, Papkovsky DB (2009) In vitro analysis of cell metabolism using a long-decay pH-sensitive lanthanide probe and extracellular acidification assay. Anal Biochem 390:21–28CrossRefPubMedGoogle Scholar
  42. 42.
    Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3:542–545PubMedGoogle Scholar
  43. 43.
    Dmitriev RI, Okkelman IA, Abdulin RA, Shakhparonov MI, Pestov NB (2009) Nuclear transport of protein TTC4 depends on the cell cycle. Cell Tissue Res 336:521–527CrossRefPubMedGoogle Scholar
  44. 44.
    Duffy S, MacVicar BA (1994) Potassium-dependent calcium influx in acutely isolated hippocampal astrocytes. Neuroscience 61:51–61CrossRefPubMedGoogle Scholar
  45. 45.
    Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M (2003) A key role for TRPM7 channels in anoxic neuronal death. Cell 115:863–877CrossRefPubMedGoogle Scholar
  46. 46.
    Falchi AM, Isola R, Diana A, Putzolu M, Diaz G (2005) Characterization of depolarization and repolarization phases of mitochondrial membrane potential fluctuations induced by tetramethylrhodamine methyl ester photoactivation. FEBS J 272:1649–1659CrossRefPubMedGoogle Scholar
  47. 47.
    Duchen MR (2000) Mitochondria and calcium: from cell signalling to cell death. J Physiol 529(Pt 1):57–68CrossRefPubMedGoogle Scholar
  48. 48.
    Duchen MR (1992) Ca(2+)-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem J 283(Pt 1):41–50PubMedGoogle Scholar
  49. 49.
    Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K (2000) Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 28:285–296CrossRefPubMedGoogle Scholar
  50. 50.
    Rizzuto R, Duchen MR, Pozzan T (2004) Flirting in little space: the ER/mitochondria Ca2+ liaison. Sci STKE 2004:re1CrossRefPubMedGoogle Scholar
  51. 51.
    Mironov SL, Symonchuk N (2006) ER vesicles and mitochondria move and communicate at synapses. J Cell Sci 119:4926–4934CrossRefPubMedGoogle Scholar
  52. 52.
    Jacobson J, Duchen MR (2002) Mitochondrial oxidative stress and cell death in astrocytes – requirement for stored Ca2+ and sustained opening of the permeability transition pore. J Cell Sci 115:1175–1188PubMedGoogle Scholar
  53. 53.
    Kaasik A, Safiulina D, Zharkovsky A, Veksler V (2007) Regulation of mitochondrial matrix volume. Am J Physiol Cell Physiol 292:C157–C163CrossRefPubMedGoogle Scholar
  54. 54.
    Baysal K, Brierley GP, Novgorodov S, Jung DW (1991) Regulation of the mitochondrial Na+/Ca2+ antiport by matrix pH. Arch Biochem Biophys 291:383–389CrossRefPubMedGoogle Scholar
  55. 55.
    Thayer SA, Miller RJ (1990) Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J Physiol 425:85–115PubMedGoogle Scholar
  56. 56.
    Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R (1999) Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci U S A 96:13807–13812CrossRefPubMedGoogle Scholar
  57. 57.
    Szewczyk MM, Pande J, Grover AK (2008) Caloxins: a novel class of selective plasma membrane Ca2+ pump inhibitors obtained using biotechnology. Pflugers Arch 456:255–266CrossRefPubMedGoogle Scholar
  58. 58.
    Pereira CM, Oliveira CR (1997) Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic Biol Med 23:637–647CrossRefPubMedGoogle Scholar
  59. 59.
    Duchen MR, McGuinness O, Brown LA, Crompton M (1993) On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 27:1790–1794CrossRefPubMedGoogle Scholar
  60. 60.
    Leyssens A, Nowicky AV, Patterson L, Crompton M, Duchen MR (1996) The relationship between mitochondrial state, ATP hydrolysis, [Mg2+]i and [Ca2+]i studied in isolated rat cardiomyocytes. J Physiol 496(Pt 1):111–128PubMedGoogle Scholar
  61. 61.
    Tsien RY, Waggoner A (1995) Fluorophores for confocal microscopy. In: Pawley JB (ed) Handbook of biological confocal microscopy, 2nd edn. Plenum Press, New York, pp 267–280Google Scholar
  62. 62.
    Huser J, Rechenmacher CE, Blatter LA (1998) Imaging the permeability pore transition in single mitochondria. Biophys J 74:2129–2137CrossRefPubMedGoogle Scholar
  63. 63.
    Buckman JF, Reynolds IJ (2001) Spontaneous changes in mitochondrial membrane potential in cultured neurons. J Neurosci 21:5054–5065PubMedGoogle Scholar
  64. 64.
    McCormack JG, Halestrap AP, Denton RM (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70:391–425PubMedGoogle Scholar
  65. 65.
    Territo PR, French SA, Dunleavy MC, Evans FJ, Balaban RS (2001) Calcium activation of heart mitochondrial oxidative phosphorylation: rapid kinetics of mVO2, NADH, and light scattering. J Biol Chem 276:2586–2599CrossRefPubMedGoogle Scholar
  66. 66.
    Gunter KK, Gunter TE (1994) Transport of calcium by mitochondria. J Bioenerg Biomembr 26:471–485CrossRefPubMedGoogle Scholar
  67. 67.
    Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 86:369–408CrossRefPubMedGoogle Scholar
  68. 68.
    Garlid KD, Paucek P (2003) Mitochondrial potassium transport: the K(+) cycle. Biochim Biophys Acta 1606:23–41CrossRefPubMedGoogle Scholar
  69. 69.
    Safiulina D, Veksler V, Zharkovsky A, Kaasik A (2006) Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume: physiological role in neurones. J Cell Physiol 206:347–353CrossRefPubMedGoogle Scholar
  70. 70.
    Brunk UT, Terman A (2002) The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269:1996–2002CrossRefPubMedGoogle Scholar
  71. 71.
    Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC (2008) Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4:849–950PubMedGoogle Scholar
  72. 72.
    Moriyama Y, Maeda M, Futai M (1992) The role of V-ATPase in neuronal and endocrine systems. J Exp Biol 172:171–178PubMedGoogle Scholar

Copyright information

© The Author(s) 2010

Authors and Affiliations

  • Alexander V. Zhdanov
    • 1
  • Ruslan I. Dmitriev
    • 1
  • Dmitri B. Papkovsky
    • 1
  1. 1.Biochemistry DepartmentUniversity College CorkCorkRepublic of Ireland

Personalised recommendations